Nelson Vergel
Founder, ExcelMale.com
The American Association of Clinical Endocrinologists (AACE) is speaking out on the use of testosterone therapy and whether it is unfairly being categorized as contributing to an increased risk for cardiovascular disease (CVD).
On Sept. 22, 2015, AACE, in conjunction with the American College of Endocrinology (ACE), issued a position statement questioning claims that testosterone therapy increases the risk for CVD among users. They cited a lack of compelling evidence connecting testosterone therapy with cardiovascular (CV) events such as heart attack and stroke.
http://www.endocrinologyadvisor.com...-therapy-cardiovascular-risks/article/441130/
On Sept. 22, 2015, AACE, in conjunction with the American College of Endocrinology (ACE), issued a position statement questioning claims that testosterone therapy increases the risk for CVD among users. They cited a lack of compelling evidence connecting testosterone therapy with cardiovascular (CV) events such as heart attack and stroke.
http://www.endocrinologyadvisor.com...-therapy-cardiovascular-risks/article/441130/
